Sponsor content
326 result(s) found, displaying 51 to 60
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.5 mg/ml nebuliser suspension.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 1mg.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 0.5mg.
-
Prescription medicine decision summaryTruqap (capivasertib), in combination with fulvestrant, is approved for the treatment of adult patients with locally advanced or metastatic breast cancer.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 0.5 mg/2 mL.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 1 mg/2 mL.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FELODIPINE AZN ER felodipine 5 mg extended release tablet blister pack.